KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 123 filers reported holding KRYSTAL BIOTECH INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,825 | +4.1% | 15,503 | 0.0% | 0.01% | 0.0% |
| Q1 2024 | $2,713 | +37.7% | 15,503 | 0.0% | 0.01% | +25.0% |
| Q4 2023 | $1,970 | +9.1% | 15,503 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $1,806 | -48.0% | 15,503 | -48.8% | 0.00% | -50.0% |
| Q2 2023 | $3,471 | +47.5% | 30,300 | 0.0% | 0.01% | +33.3% |
| Q1 2023 | $2,354 | -1.0% | 30,300 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $2,377 | -99.9% | 30,300 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $2,106,000 | +9.9% | 30,300 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $1,916,000 | +13.2% | 30,300 | +19.8% | 0.01% | +50.0% |
| Q1 2022 | $1,693,000 | +173.5% | 25,300 | +187.5% | 0.00% | +100.0% |
| Q4 2021 | $619,000 | +36.6% | 8,800 | +2.3% | 0.00% | +100.0% |
| Q3 2021 | $453,000 | -22.7% | 8,600 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $586,000 | -5.8% | 8,600 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $622,000 | +72.3% | 8,600 | +34.4% | 0.00% | +100.0% |
| Q4 2020 | $361,000 | – | 6,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 895,000 | $68,951,000 | 5.53% |
| S Squared Technology, LLC | 85,215 | $6,565,000 | 3.10% |
| First Light Asset Management, LLC | 491,511 | $37,866,000 | 2.51% |
| Soleus Capital Management, L.P. | 166,844 | $12,854,000 | 2.32% |
| Redmile Group, LLC | 2,060,132 | $158,713,000 | 2.24% |
| Nicholas Investment Partners, LP | 304,689 | $23,473,000 | 1.64% |
| HighMark Wealth Management LLC | 17,192 | $1,324,000 | 1.06% |
| DSAM Partners (London) Ltd | 70,274 | $5,414,000 | 1.00% |
| Artal Group S.A. | 500,000 | $38,520,000 | 0.68% |
| Hood River Capital Management LLC | 237,882 | $18,326,000 | 0.59% |